Mcrae Capital Management Inc / TMO
Mcrae Capital Management Inc’s Thermo Fisher Scientific Inc Position
Does Mcrae Capital Management Inc own Thermo Fisher Scientific Inc (TMO)? Yes — 28.8K shares worth $14M (+2.93% of its 13F portfolio) as of Q1 2026, down from 29.2K shares the prior filed quarter.
Position Value
$14M
Q1 2026
Shares
28.8K
% of Portfolio
+2.93%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 28.8K | $14M | +2.93% |
| Q4 2025 | 29.2K | $17M | +3.45% |
| Q3 2025 | 30.8K | $15M | +2.96% |
| Q2 2025 | 30.8K | $12M | +2.56% |
| Q1 2025 | 27.5K | $14M | +2.88% |
| Q4 2024 | 27.8K | $14M | +2.83% |
| Q3 2024 | 25.7K | $16M | +3.10% |
| Q2 2024 | 25.8K | $14M | +3.26% |
| Q1 2024 | 25.7K | $15M | +3.27% |
| Q4 2023 | 24.7K | $13M | +3.28% |
| Q3 2023 | 20.7K | $10M | +3.10% |
| Q2 2023 | 12.0K | $6M | +1.78% |
| Q1 2023 | 11.8K | $7M | +1.96% |
| Q4 2022 | 11.3K | $6M | +1.83% |
| Q3 2022 | 11.9K | $6M | +1.83% |
| Q2 2022 | 12.0K | $6M | +1.76% |
| Q1 2022 | 12.1K | $7M | +1.61% |
| Q4 2021 | 12.1K | $8M | +1.68% |
| Q3 2021 | 12.1K | $7M | +1.52% |
| Q2 2021 | 11.6K | $6M | +1.34% |
| Q1 2021 | 12.6K | $6M | +1.42% |
| Q4 2020 | 12.5K | $6M | +1.68% |
| Q3 2020 | 12.6K | $6M | +1.87% |
| Q2 2020 | 12.6K | $5M | +1.71% |
| Q1 2020 | 12.8K | $4M | +1.77% |
| Q4 2019 | 12.8K | $4M | +1.53% |
| Q3 2019 | 13.0K | $4M | +1.47% |
| Q2 2019 | 12.9K | $4M | +1.51% |
| Q1 2019 | 12.8K | $3M | +1.45% |
| Q4 2018 | 2.6K | $589,000 | +0.30% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mcrae Capital Management Inc’s full portfolio or all institutional holders of TMO.